Pfizer Reports 80% Biosimilars Growth In Q3

Company Expects To Close Upjohn-Mylan Transaction In Q4

 
• By Akriti Seth
  
BusinessGraph
Pfizer has seen its biosimilars sales leap in Q3 • Source: Shutterstock

More from Deals

More from Business